Nilotinib Capsule
Product Images NDC 43598-456

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Nilotinib (NDC 43598-456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Packaging label for Nilotinib Capsules 50 mg by Dr. Reddy's Laboratories Inc. This human prescription drug is in oral capsule form, with a total count of 112 capsules divided into 4 blister packs of 28 capsules each. The label includes dosing instructions advising to take on an empty stomach and storage conditions.*

FDA Label Image

Carton2 (Carton2)

The packaging label for Nilotinib Capsules 150 mg by Dr. Reddy's Laboratories Inc features information for 112 capsules (4 individual blister packs containing 28 capsules each). The label includes dosage instructions to take on an empty stomach with food avoidance guidelines, storage conditions, pharmacist dispensing instructions, NDC 43598-455-67, and distributor details listing Dr. Reddy's Laboratories, Princeton, NJ.*

FDA Label Image

Carton3 (Carton3)

Packaging label for Nilotinib Capsules 200 mg, oral capsules, manufactured by Dr. Reddy's Laboratories Inc. The label states the package contains 112 capsules divided into 4 blister packs of 28 capsules each. Instructions include taking the capsules on an empty stomach and storing at controlled room temperature. The label includes dispensing instructions for pharmacists and a contact phone number for additional information.*

FDA Label Image

Carton4 (Carton4)

Nilotinib Capsules 50 mg packaging label from Dr. Reddy's Laboratories Inc. The label indicates a package containing 112 capsules divided into 8 individual blister packs of 14 capsules each. The label provides dosing instructions to take capsules on an empty stomach and cautions to avoid food for at least 2 hours before and 1 hour after dosing. It includes pharmacist dispensing instructions and storage conditions. The label is predominantly white with orange and blue text elements.*

FDA Label Image

Carton5 (Carton5)

Packaging label for Nilotinib Capsules 150 mg by Dr. Reddy's Laboratories Inc. The label states the package contains 112 capsules in 8 blister packs of 14 capsules each. Additional information includes storage instructions, a pharmacist dispensing note, and dosing advice to take capsules on an empty stomach.*

FDA Label Image

Carton6 (Carton6)

Packaging label for Nilotinib Capsules 200 mg, an oral capsule prescription drug by Dr. Reddy's Laboratories Inc. The label indicates a package containing 112 capsules divided into 8 individual blister packs with 14 capsules each. The label includes storage instructions, usage warnings, a barcode, and medication guide dispensing instructions.*

FDA Label Image

Container1 (Container1)

Label for Nilotinib Capsules 50 mg by Dr. Reddy's Laboratories Inc., an oral capsule for prescription use. The label indicates a count of 120 capsules and includes dosage instructions to take on an empty stomach, avoiding food 2 hours before and 1 hour after dosing. It displays the NDC number 43598-055-04 and includes storage instructions and pharmacist dispensing guidance.*

FDA Label Image

Container2 (Container2)

Label for Nilotinib Capsules 150 mg by Dr. Reddy's Laboratories Inc. The label includes dosage form as capsules, prescription-only status, storage instructions, and a 28-capsule count. It instructs pharmacists to dispense the medication guide and provides dosing advice to take capsules on an empty stomach. Contains manufacturer and barcode details.*

FDA Label Image

Container3 (Container3)

Label for Nilotinib Capsules 200 mg oral capsules by Dr. Reddy's Laboratories Inc. The label includes dosage instructions to take capsules on an empty stomach and to avoid food 2 hours before and 1 hour after dosing. The package contains 28 capsules. The label also shows storage conditions, barcode, and the NDC 43598-456-63.*

FDA Label Image

Figure1 (Figure1)

A Kaplan-Meier curve illustrating treatment-free survival percentage over time in weeks since treatment-free remission (TFR). The graph features a survival curve with upper and lower confidence limits and marks for censored observations, alongside a risk table showing the number of patients at risk and events at various time points up to around 132 weeks.*

FDA Label Image

Figure2 (Figure2)

A Kaplan-Meier survival curve chart depicting treatment-free survival percentage over time in weeks since treatment failure (TFR). The chart includes a main survival curve with dashed confidence intervals, censored observations marked by vertical ticks, and an at-risk table showing patient counts and event counts over time.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Nilotinib, a pharmaceutical active ingredient. The structure shows multiple aromatic rings, nitrogen-containing heterocycles, methyl, fluorine, and chloride groups, representing the detailed molecular arrangement of Nilotinib.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.